The slip
PARKINSON RECEIPTno. 11540
27 Oct 2026, 04:08 UTCdopamine neurons, braak
predictionZSCAN12 in dopamine neurons tracks Braak Lewy-body stage
registered8febfc4163154845
discovery+0.29 p=0.457 n=9
replication+0.02 p=0.965 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.29, p 0.457)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTe66b1459dbc2a3200e8757d0…
follows 5c9c7197a619…
Covered by the on-chain checkpoint of receipt 11553 (2026-10-27 04:27 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 11540: ZSCAN12 in dopamine neurons, braak
- power
- full sample +0.14 (p 0.585, n 18), 95% CI -0.35 to +0.57. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.17 (p 0.504, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.10 (p 0.702, n 18). could be the mix.
- skeptic
- leave-one-out range +0.04 to +0.28, sign flips 0; without severely affected donors +0.14 (p 0.585, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ZSCAN12 in dopamine neurons.
case closed: nothing better to follow up.